Mixed cellular Hodgkin lymphoma, intrathorac nodes is a subtype of Hodgkin lymphoma characterized by the presence of mixed cellularity in lymphoid tissue, primarily affecting the intrathoracic lymph nodes. This condition is clinically significant due to its potential for systemic symptoms and complications. Accurate coding with ICD-10 Code C81.22 ensures proper diagnosis, documentation, and billing, facilitating effective treatment and public health reporting.
What is ICD-10 Code C81.22 for Mixed cellular Hodgkin lymphoma, intrathorac nodes?
ICD-10 Code C81.22 specifically denotes Mixed cellular Hodgkin lymphoma affecting the intrathoracic lymph nodes. This code is utilized in clinical documentation to identify the presence of this lymphoma subtype, which may present with various symptoms and complications. It is essential for accurate billing and tracking of healthcare services related to this condition.
ICD-10 Code C81.22 – Clinical Definition and Explanation of Mixed cellular Hodgkin lymphoma, intrathorac nodes
Mixed cellular Hodgkin lymphoma, intrathorac nodes is a hematological malignancy that arises from the lymphatic system, characterized by a heterogeneous population of cells. The condition can progress rapidly and often requires immediate medical intervention due to its potential to cause significant morbidity. Key clinical features include:
Key Clinical Features:
- Presence of lymphadenopathy in the thoracic region.
- Systemic symptoms such as fever, night sweats, and weight loss.
- Potential for respiratory symptoms due to lymph node enlargement.
- Histological confirmation through biopsy showing mixed cellularity.
ICD-10 Code C81.22 for Mixed cellular Hodgkin lymphoma, intrathorac nodes – SOAP Notes & Clinical Use
ICD-10 Code C81.22 is integral to SOAP notes, aiding in the documentation of patient symptoms, assessments, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.
What Does ICD-10 Code C81.22 for Mixed cellular Hodgkin lymphoma, intrathorac nodes Mean in SOAP Notes?
In SOAP notes, ICD-10 Code C81.22 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Mixed cellular Hodgkin lymphoma. This linkage is crucial for continuity of care, supporting billing processes, and meeting EHR documentation standards.
Treatment Options for ICD-10 Code C81.22 – Mixed cellular Hodgkin lymphoma, intrathorac nodes
Management of Mixed cellular Hodgkin lymphoma, intrathorac nodes often necessitates hospitalization due to the potential for severe complications. Treatment approaches include:
Antibiotic Therapy:
- Not applicable as this is not an infectious condition.
Supportive Care:
- Chemotherapy regimens such as ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine).
- Radiation therapy for localized disease.
- Symptom management including pain control and nutritional support.
Infection Control:
- Standard precautions to prevent infections in immunocompromised patients.
- Monitoring for febrile neutropenia during chemotherapy.
How to Document Symptoms of Mixed cellular Hodgkin lymphoma, intrathorac nodes (ICD-10 C81.22) in SOAP Notes
Subjective:
- Patient reports persistent cough and chest discomfort.
- History of unexplained weight loss over the past month.
- Experiencing night sweats and fatigue.
- No known allergies or previous malignancies.
Objective:
- Physical examination reveals enlarged supraclavicular and mediastinal lymph nodes.
- Chest X-ray shows mediastinal widening.
- Vital signs: BP 120/80 mmHg, HR 88 bpm, Temp 99.5°F.
- CBC shows anemia and elevated white blood cell count.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Mixed cellular Hodgkin lymphoma, intrathorac nodes (ICD-10 Code C81.22)
Assessment:
- Diagnosis: Mixed cellular Hodgkin lymphoma, intrathoracic nodes, Stage II.
- ICD-10 Code: C81.22.
- Contributing factors: Possible viral etiology (EBV).
- Severity: Moderate to severe based on clinical presentation.
Plan:
- Initiate chemotherapy with ABVD regimen.
- Refer to oncology for further management.
- Educate patient on potential side effects and symptom monitoring.
- Schedule follow-up in 4 weeks for reassessment.
Treatment & Plan Section for ICD-10 Code C81.22 – Mixed cellular Hodgkin lymphoma, intrathorac nodes
- First-line treatment includes chemotherapy with ABVD regimen.
- Consider radiation therapy for localized disease after chemotherapy.
- Monitor for treatment-related complications such as infections and anemia.
- Provide patient education on lifestyle modifications and support resources.
Using ICD-10 Code C81.22 for Mixed cellular Hodgkin lymphoma, intrathorac nodes in Billing & SOAP Note Compliance
- Select appropriate ICD-10 code based on clinical documentation of the condition.
- Ensure Subjective (S) and Objective (O) sections reflect the patient's symptoms and clinical findings accurately.
- Align treatment plans with clinical guidelines to support justified billing.
- Document any relevant CPT codes that correspond with the services provided.
Related ICD-10 Codes Often Used with Mixed cellular Hodgkin lymphoma, intrathorac nodes
- C81.20 – Hodgkin lymphoma, unspecified site
- C81.21 – Mixed cellular Hodgkin lymphoma, lymph nodes of head, face, and neck
- C81.23 – Mixed cellular Hodgkin lymphoma, lymph nodes of axilla and upper limb
- C81.24 – Mixed cellular Hodgkin lymphoma, lymph nodes of abdomen
ICD-10 Code C81.22 in Medical Billing and Insurance for Mixed cellular Hodgkin lymphoma, intrathorac nodes
ICD-10 Code C81.22 is crucial for billing in hospital, ER, or infectious disease care settings.
Billing Notes:
- Document all relevant clinical findings and treatment plans to support the ICD-10 claim.
- Use this code in conjunction with appropriate CPT codes for chemotherapy and follow-up visits.
- Ensure that documentation reflects the severity and complexity of the patient's condition.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 99214 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with automated differential. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C81.22 for Mixed cellular Hodgkin lymphoma, intrathorac nodes
What are the common symptoms of Mixed cellular Hodgkin lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, unexplained weight loss, and fatigue. Patients may also experience respiratory symptoms if intrathoracic nodes are involved.
How is Mixed cellular Hodgkin lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of Hodgkin lymphoma cells.
What is the treatment for Mixed cellular Hodgkin lymphoma?
Treatment usually involves chemotherapy, often with the ABVD regimen, and may include radiation therapy depending on the stage and location of the disease.
Is Mixed cellular Hodgkin lymphoma contagious?
No, Hodgkin lymphoma is not contagious. It is a type of cancer that arises from the lymphatic system and is not spread from person to person.
